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Background: Spanish is one of the five most spoken languages in the world. There is currently no published
Spanish version of the Örebro Musculoskeletal Pain Questionnaire (OMPQ). The aim of the present study is to
describe the process of translating the OMPQ into Spanish and to perform an analysis of reliability, internal
structure, internal consistency and concurrent criterion-related validity.
Methods: Design: Translation and psychometric testing. Procedure: Two independent translators translated the
OMPQ into Spanish. From both translations a consensus version was achieved. A backward translation was made to
verify and resolve any semantic or conceptual problems. A total of 104 patients (67 men/37 women) with a mean
age of 53.48 (±11.63), suffering from chronic musculoskeletal disorders, twice completed a Spanish version of the
OMPQ. Statistical analysis was performed to evaluate the reliability, the internal structure, internal consistency and
concurrent criterion-related validity with reference to the gold standard questionnaire SF-12v2.
Results: All variables except “Coping” showed a rate above 0.85 on reliability. The internal structure calculation
through exploratory factor analysis indicated that 75.2% of the variance can be explained with six components with
an eigenvalue higher than 1 and 52.1% with only three components higher than 10% of variance explained. In the
concurrent criterion-related validity, several significant correlations were seen close to 0.6, exceeding that value in
the correlation between general health and total value of the OMPQ.
Conclusions: The Spanish version of the screening questionnaire OMPQ can be used to identify Spanish patients
with musculoskeletal pain at risk of developing a chronic disability.
Keywords: Musculoskeletal pain, Reliability, Validity, Outcome, Factor analysis, Clinimetric, MeasurementBackground
Chronic musculoskeletal conditions have a negative impact,
affecting the well-being, independence and physical and
psychological health of those who suffer [1]. The incidence
of such diseases is very high, with an estimated overall
prevalence in the general adult population of a person
suffering a low back pain (LBP) episode in his/her lifetime
ranging between 60% and 85% [2], with a high impact on
socio-economic cost [1,3].* Correspondence: acuesta@uma.es
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this article, unless otherwise stated.Clinical practice guidelines in primary care based
on musculoskeletal evidence show the importance of
identifying indicators of poor outcomes need to be
considered when achieving the rehabilitative process
[4]. Several studies have been published showing the
interaction between the patient’s psychosocial status
and the probability increase for a musculoskeletal problem
becoming chronic [5]. These psychological factors have
been shown as good predictors of long-term disabilities
[6], developing a correlation in which the experience of
pain is associated with disability. Biomedical professionals
spend a considerable amount of time with their patients
and are aware of the importance that psychosocial factors
have. Nevertheless, the ways to face these factors arelicensee BioMed Central Ltd. This is an Open Access article distributed under the
icense (http://creativecommons.org/licenses/by/4.0), which permits unrestricted
ium, provided the original work is properly credited. The Creative Commons
ivecommons.org/publicdomain/zero/1.0/) applies to the data made available in
Table 1 Descriptive data of the sample
Minimum Maximum Mean Stand. Dev
Age (Years) 29 69 53.48 11.63
Height (cm) 149.0 184.0 164.8 9.09
Weight (Kg) 51 99 74.27 12.08
BMI (Kg/m2) 21.5 34.2 27.22 3.51
Pain appearance Suddenly 40 (38.5%)
Gradually 64 (61.5%)
Pain duration 6 w – 3 m 9 (7.7%)
3 m – 12 m 11 (11.5%)
+ 12 m. 83 (80.5%)
LBP previous episode Yes 95 (92.3%)
No 9 (7.7%)
Economic compensation Yes 9 (7.7%)
No 95 (92.3%)
Employment status Active 64 (61.5%)
Sick Leave 12 (11.5%)
Pensioner 28 (27.0%)
N (♀/♂) 104 (67/37)
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differences of an eventual intervention [7].
Linton et al. developed the screening questionnaire
Örebro Musculoskeletal Pain Questionnaire (OMPQ)
in 1998 [8]. This screening questionnaire relates to and
assesses the patient’s bio-psychosocial aspects. The scored
items evaluate pain location, work absence due to pain,
pain duration, pain intensity, control over the pain, fre-
quency of pain episodes in the past three months,
functional ability, mood perceptions of work, patient’s
estimate of prognosis and fear avoidance [9]. A score
of <105 points (max value is 210) indicates low disabil-
ity, a score between 105 and 130, moderate disability,
and a higher score, high disability, where the specificity
and sensibility in assessed disability show 0.75 and 0.88
respectively [8]. It has a predictive validity ranging be-
tween 0.62–0.75 for pain and 0.68–0.83 for disability
[9,10]. It has also shown the same predictability in
countries as diverse as Norway and Australia [11]. Add-
itionally, the OMPQ has been externally validated by
multiple international studies [10-13]. As a result of all
these factors, the OMPQ is currently considered a ref-
erence tool when comparing questionnaires of similar
characteristics [14].
We have not found published reports indicating that
the Spanish versions of the OMPQ have followed the
proposed guidelines for translation and cross-cultural
adaptation, or that their psychometric properties have
been tested. Spanish is one of the five most spoken
languages in the world [15]. We created the Spanish
version of the screening questionnaire OMPQ to facilitate
its introduction and use in Spanish clinical and scientific
endeavours.
One of the questionnaires most widely used to evalu-
ate people’s quality of life is the SF-12, whose properties
have been demonstrated in more than 400 articles [16].
The main reason for the development of SF-12 was to
make a questionnaire that could be reproduced on a
single page and completed in a short time (about two
minutes), and would be able to represent the summa-
tion of the general measures of physical and mental
health survey SF-36 with an accuracy level above 90%
[17]. By frequency of use and scientific validity, it can be
said that the objective was clearly achieved. The main
limitations that could be seen in this survey were the
number of variables that could be obtained, while the
extended version obtained eight items. This problem
has been solved with the development SF-12v2 [18],
which can obtain the same variables as the SF-36 in less
time. The objective of this study is to describe the
process of translation of the OMPQ into Spanish and
perform analysis of reliability, factor structure, construct
validity and concurrent criterion-related validity with
the SF-12v2.Materials and methods
Participants
One hundred and four (104) persons participated in the
present study. All participants were recruited in a com-
munity health centre localized in Torremolinos (Spain).
All participants in this study suffer from musculoskeletal
disorders (back pain, neck pain or osteoarthritis). The
musculoskeletal disorders could be acute, sub-acute or
chronic (please, see Table 1 for a more accurate sample
description). The inclusion criteria were specific for each
of the diseases included. These were: Low back pain:
Non-specific low back pain, without radiation to lower
limbs, more than six weeks of development [13]; Neck
pain: Patients with neck pain and interference in their daily
living activities, but no neurological signs; Osteoarthritis:
People with joint pain that causes stiffness, deformity and
loss of movement.
By contrast, the exclusion criteria used were common
to the three conditions: patient refusal to participate in the
study, infectious processes, neoplasm, metastasis, osteo-
porosis, inflammatory arthritis or fractures and cognitive
impairment of any etiologic. Data were collected between
April 2013 and December 2013.
Ethics
All participants, after receiving both written and oral
information about the project, signed their informed con-
sent. Ethical approval for the study was granted by the eth-
ics committee of the Faculty of Health Sciences, University
of Malaga. This study was conducted in accordance with
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Subjects (Declaration of Helsinki 2008). The protec-
tion of their personal data was performed according to
the Spanish Organic Law of Protection of Personal Data
19/55.
Questionnaires
The Örebro musculoskeletal pain questionnaire
The Örebro Musculoskeletal Pain Questionnaire [8] is a
clinical tool used for identification of patients at risk of
developing chronic or long-term musculoskeletal prob-
lems. The questionnaire includes 25 questions, of which
21 are rated on a scale of 0–10, with a maximum possible
score of 210 points.
The response of the patient will have a value, depending
on the question. The value of a response to question 5 will
be doubled. For questions 12, 16, 17, 21–25 the score is
10 minus the number that has been circled. For questions
6–11, 13–15, 18–20 the score is the number that has been
ticked or circled.
These questions are divided into six different subgroups.
The total score is derived from the sum of the values of all
items. However, the response to certain questions con-
strains the value of six different subgroups.
Short Form 12 Version 2 (SF-12v2)
The SF-12 [17] is composed of a subset of 12 items of
the SF-36, selected by multiple regression (selecting
one or two items from each of the dimensions of the
SF-36), from which, initially, the only ratings were built
from a summary of physical and mental components,
which, in the second version, became eight components
(as in the SF-36). These components are: Physical
Function, Physical Role, Emotional Role, Social Func-
tion, Mental Health, General Health, Bodily Pain and
Vitality [17,18].
Procedure
Data collection
Each patient completed the Spanish OMPQ twice, sep-
arated by three days, so that any type of treatment
would not affect the participant’s situation. On the first
occasion, each patient completed the Spanish OMPQ,
while on the second, both Spanish OMPQ and SF-12v2
were completed, as different questions allowed a clearer
definition of group participants.
Translation and cultural adaptation of the OMPQ into the
Spanish OMPQ
Following the recommendations of the scientific literature
[16], we made a backward translation, so that the equiva-
lence concept used by the author was guaranteed. Here
are the steps followed for the translation and back transla-
tion of the OMPQ (Figure 1):1. There were two independent translations, produced
by two professional translators, into Spanish. Both
versions were compared and, after consensus,
drafted into a single document.
2. The original document was compared with a copy of
the translation to make a conceptual, as well as
semantic, equivalence between the two texts.
3. The document was implemented in clinical practice.
The format of the Spanish adaptation of OMPQ is
similar to the original, made with the permission of the
author (Additional file 1).
Statistical analysis
Descriptive analysis was applied to calculate means
(±standard deviation) of demographic variables and
the Spanish OMPQ. Statistical analysis was performed
to evaluate the internal structure, internal consistency
and concurrent criterion-related validity. Exploratory
factor analysis with maximum likelihood extraction and
varimax rotation was estimated for the internal structure
of the new questionnaire. Reliability was considered as
a test-retest standard deviation of differences either as
the 95% limits of agreement [19,20].To determine the
internal consistency of the scale items, Cronbach’s α
coefficients were calculated. Excellent (ICC >0.80), good
(0.80 > ICC >0.60), moderate (0.60 > ICC >0.40) and poor
(ICC <0.40) were the levels of reliability [21]. Likewise,
concurrent criterion-related validity was taken as the ref-
erence questionnaire SF-12v2. Kolmogorov–Smirnov (KS)
was performed to determine the distribution of the sample
and from this, make a bivariate correlation by Pearson (for
parametric) or Spearman (for nonparametric). This ana-
lysis was performed using statistical analysis software SPSS
version 17.0.
Results
Translation and cultural adaptation
Taking the OMPQ original text as a starting point, the
two professional translators had virtually identical docu-
ments which both facilitated the preparation of the final
agreed draft of the document, and resulted in a ques-
tionnaire identical to the original with which we started.
The descriptive characteristics of subjects who agreed
to complete the questionnaires following the protocol
described earlier are shown in Table 1.
Internal structure: factor analysis
The results obtained in the calculation of the internal
structure through factor analysis with maximum likeli-
hood extraction, where the 52.1% of the variance can be
explained with three components with an eigenvalue
higher than 1 and 10% variance explained and 75.2% with
six with an eigenvalue higher than 1, can be observed in
Spanish OMPQ 
FINAL DOCUMENT TRANSLATED
TRANSLATOR 1
The Örebro Musculoskeletal Pain Questionnarire
Original Version
TRANSLATOR 2
CONSENSUS DOCUMENT
COMPARATION BOTH DOCUMENTS
REVERSE TRANSLATION
COMPARED TO THE ORIGINAL
LOOKIN FOR CONCEPTUAL AND SEMANTIC EQUIVALENCE
Figure 1 Flowchart of the development process OMPQ spanish version.
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component matrix (Table 3). The rotation process seeks
to simplify the structure of looking at how each question
saturates the various components in the OMPQ question-
naire decays. Ideally, the saturation level of a question
should be close to 1, so that it saturates on a single
component. However, it has been noted how some
questions have a moderate saturation and saturate on
more than one component. Specifically, questions Q11
“Risk Chronic” and Q16 “Belief: not work” saturate onTable 2 Total variance explained
Component Eigenvalues
Total % of variance Cumulative%
1 5.190 24.712 24.712
2 3.566 16.982 41.694
3 2.197 10.461 52.154
4 1.822 8.674 60.829
5 1.659 7.900 68.729
6 1.362 6.486 75.215
Extraction Method: Maximun likehood extraction.two components. Question Q11 saturates on the compo-
nents 1 and 4 with levels of 0.462 and 0.569 respectively,
while question Q16 saturates on components 1 and 2 with
levels of 0.516 and 0.529 respectively. The rest of the
saturation levels for each question to saturate the com-
ponents are shown in Table 3.
Reliability and internal consistency
The values obtained after the study on the reliability
by calculating the ICC (2, 1), and the corresponding
Cronbach α are observable in Table 4. In this table it
can be seen how the range of reliability varies between
0.853 (average pain) and 1 (duration) except for the
“Coping” variable which has a reliability of 0.218.
Concurrent-criterion validity
Table 5 shows the results obtained by conducting bivariate
correlations between variables resulting from the Spanish
OMPQ and SF-12 V2. Items that were parameters were
calculated through the Pearson correlation coefficient,
whereas we used the Spearman correlation coefficient
for nonparametric variables. The values of the signifi-
cant bivariate correlations vary between 0.325 (Physical
Table 3 Factor structure of rotated component matrix
Component
1 2 3 4 5 6
Q19. Household work 0.919
Q17. Light work 0.850
Q18. Walk 0.848
Q12. Chance working 0.577
Q20. Shopping 0.522
Q1.Pain site 0.518
Q16. Belief: not work 0.516 0.529
Q11. Risk Chronic 0.462 0.569
Q7. Frequency 0.700
Q13. Job satisfaction 0.882
Q9. Stress 0.880
Q10. Depressión 0.892
Q8. Coping 0.692
Q21. Sleep 0.649
Q6. Average pain 0.620
Q3. Duration 0.561
Q2. Sick leave 0.812
Q14. Belief: increase 0.707
Q4. Heavy work 0.851
Q15. Belief: stop 0.500
Q5. Current pain 0.487
Extraction Method: Maximun likehood extraction.
Rotation Method: Varimax with Kaiser Normalization.
Supression at 0.35.
Table 4 Reliability and internal consistency
Variable Cronbach
alpha
Lower Bound
ICC(2.1) 95%CI
Upper Bound
ICC(2.1) 95%CI
Pain site 0.978 0.968 0.985
Sick leave 0.903 0.857 0.934
Duration 1.000 1.000 1.000
Heavy work 0.883 0.828 0.921
Current pain 0.946 0.920 0.963
Average pain 0.853 0.784 0.901
Frequency 0.918 0.879 0.944
Pain 0.936 0.905 0.956
Coping 0.218 −0.153 0.470
Coping 0.218 −0.153 0.470
Stress 0.935 0.904 0.956
Depression 0.861 0.796 0.906
Distress 0.917 0.878 0.944
Risk Chronic 0.939 0.909 0.958
Chance working 0.884 0.829 0.921
Job satisfaction 0.859 0.793 0.905
Return work ex 0.941 0.912 0.960
Belief: increase 0.906 0.861 0.936
Belief: stop 0.879 0.821 0.918
Belief: not work 0.898 0.850 0.931
Fear avoidance 0.928 0.894 0.951
Light work 0.887 0.834 0.923
Walk 0.986 0.980 0.991
Household work 0.892 0.840 0.926
Shopping 0.860 0.793 0.905
Sleep 0.925 0.889 0.949
Function 0.934 0.902 0.955
Total 0.967 0.951 0.978
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the bivariate correlations can be seen in Table 5.
Discussion
The purpose of the present study was to translate and
cross-culturally adapt the screening questionnaire OMPQ
into Spanish and then to examine the psychometric prop-
erties of the Spanish OMPQ. No difficulties were encoun-
tered in translating the questionnaire, and the Spanish
Version of the OMPQ was demonstrated to be reliable
and valid to identify Spanish patients with musculoskeletal
pain at risk of developing into a disabling persistent
problem.
There are some specialized methods of translation and
cross-cultural adaptation of questionnaires of quality of
life and health which can greatly facilitate the translation
process, especially by avoiding certain problems that may
arise in drafting the consensus document, as well as an
understanding of reverse translation. Patients demon-
strated no problems in completing and understanding
the Spanish OMPQ. This facilitated the original author’s
approach for the OMPQ.The determination of a six-factor structure using
maximum likelihood extraction was consistent with the
previously reported [6,22] and more closely approximate
Acute Low Back Pain Screening Questionnaire proposed
construct [8,22].
Furthermore, the calculations to assess the concurrent-
criterion validity of the Spanish OMPQ, with reference to
the general health questionnaire SF-12v2 is possible to ob-
serve, as all dimensions demonstrate a significant result
with at least one of the variables from the reference ques-
tionnaire. Thus, the dimensions “Pain”, “Distress”, and
“Work Return Expectancy” show statistically significant
correlations with the SF-12v2 variables “General Health”,
“Social Functioning” and “Physical Function” respectively.
In turn, the dimensions “Coping”, “Function” and “Fear
Avoidance” offer significant correlations with a larger
Table 5 Bivariate relationships between the different dimensions of OMPQ and SF-12v2
Pain Coping Distress RWE FA Function Total
Physical_Function −0.306 −0.001 0.113 −0.103 −0.405* −0.460* −0.427*
Sig (p) 0.128 0.996 0.581 0.615 0.040 0.018 0.030
Role_Physical −0.193 −0.249 0.274 −0.325* −0.493** −0.263 −0.366*
Sig (p) 0.234 0.134 0.086 0.047 0.002 0.100 0.020
Bodily_Pain 0.304 0.534** −0.084 0.294 0.438* 0.573** 0.543**
Sig (p) 0.132 0.005 0.683 0.145 0.025 0.002 0.004
General_Health 0.447** 0.232 0.069 0.317 0.392* 0.542** 0.610***
Sig (p) 0.006 0.167 0.669 0.056 0.016 0.001 0.000
Vitality 0.077 0.120 0.292 0.209 −0.030 0.277 0.153
Sig (p) 0.631 0.465 0.065 0.198 0.848 0.080 0.327
Social_Functioning −0.161 −0.367* −0.344* −0.060 −0.101 −0.240 −0.229
Sig (p) 0.320 0.027 0.032 0.713 0.529 0.134 0.148
Role_Emotional −0.151 −0.585** −0.049 −0.189 −0.121 −0.190 −0.266
Sig (p) 0.462 0.002 0.811 0.354 0.556 0.352 0.189
Mental_Health −0.080 −0.315 −0.037 −0.098 −0.170 −0.151 −0.200
Sig (p) 0.697 0.117 0.859 0.633 0.408 0.463 0.328
*= p<0.05.
**= p<0.005.
***= p <0.001.
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“Bodily Pain”, “Social Functioning” and “Emotional Role”,
moderately significant in the first two correlations. The
second of these, however, shows a statistically significant
correlation with the variable “Physical Function”, raising
the level of significance when correlated moderately with
“Bodily Pain and General Health”. However, in the third
index, there is a greater number of significant correlations
with the variables of SF-12v2. The significance level
is moderate when correlated with the variables “Physical
Role”, “Physical Function”, “Bodily Pain” and “General
Health”. It is important to note that almost all of the
correlations that demonstrate a statistical significance
have a weak strength of association with the variables
of SF-12v2. However, all correlations with indices that
are above 0.5 indicate a moderate or high significance.
This justifies the conclusion that not only the chance
of this relationship is reduced, but also the strength
of the correlation between the two questionnaires
increases.
The level of confidence shown by the Spanish OMPQ
is excellent as rated by Mancini et al. [21]. All levels
of reliability were shown superior to 0.85 except for
“Coping”, which had a poor reliability displaying a
value of 0.218.These values demonstrated the high
stability of all the items in the Spanish OMPQ.
A weakness of this study is that no outcome tool is
used to quantify change over time as a correlation to
time and recovery, so there are no cut offs that arespecific to a Spanish population. Hence, in terms of
true validity, the tool can only be used in those popula-
tions where the original tool is validated but they have
Spanish speakers as well. The lack of predictive capacity in
the Spanish version of the OMPQ indicates that it is rec-
ommendable to use the predictive ability of other versions
[8,17,23,24]. Future work needs to validate the predictive
capacity in Spanish speaking populations and this cannot
be done till the scale is presented in a translated form
which this study did. In addition, the sample included
acute, sub-acute and chronic musculoskeletal disease
patients and the psychometric properties of the ques-
tionnaire may be different among acute and chronic
pain patients.
Analyzing the results, the main conclusion of this study
is that the Spanish version of the screening questionnaire
OMPQ is a tool that can be used as an instrument with a
high reliability for assessment and monitoring of patients
with musculoskeletal pain at risk of a chronic disability.Additional file
Additional file 1: Örebro Musculoskeletal Pain Questionnaire
Spanish Version.Abbreviations
KS: Kolmogorov – smirnov; LBP: Low back pain; OMPQ: Örebro
musculoskeletal pain questionnaire.
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